VEEV · Veeva Systems

Back to holdings

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics.

Close · 3M

+99.20%

Held by 1 AI ETF

AIEQ0.060%

as of Oct 26

Signal performance

Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.

Buy signals12

Win rate100% (12/12)

Avg buy return+35.57%

AIEQnow 0.060% of fund14 signals

AIEQ · Sudden change · 1d

weight 1.280% → 0.050% (-1.230 pp)·stock up 1.0% in the 30 days before

Oct 1·entry $281.93·now $323.04

+14.58%

since Oct 1

AIEQ · Weight increase · 3d

weight 1.180% → 1.270% (+0.090 pp)·stock up 14.6% in the 30 days before

Sep 27·entry $279.96·now $323.04Chased

+15.39%

since Sep 27

AIEQ · Weight increase · 2d

weight 1.180% → 1.250% (+0.070 pp)·stock up 14.6% in the 30 days before

Sep 25·entry $280.68·now $323.04Chased

+15.09%

since Sep 25

AIEQ · Weight decrease · 3d

weight 1.220% → 1.180% (-0.040 pp)·stock up 3.7% in the 30 days before

Sep 20·entry $261.31·now $323.04

+23.62%

since Sep 20

AIEQ · Weight decrease · 2d

weight 1.220% → 1.200% (-0.020 pp)·stock up 3.7% in the 30 days before

Sep 18·entry $260.21·now $323.04

+24.15%

since Sep 18

AIEQ · Weight increase · 2d

weight 1.180% → 1.220% (+0.040 pp)·stock up 11.1% in the 30 days before

Sep 16·entry $264.90·now $323.04Chased

+21.95%

since Sep 16

AIEQ · Weight decrease · 2d

weight 1.220% → 1.180% (-0.040 pp)·stock up 10.3% in the 30 days before

Sep 10·entry $260.98·now $323.04

+23.78%

since Sep 10

AIEQ · Sudden change · 1d

weight 0.070% → 1.270% (+1.200 pp)·stock up 35.4% in the 30 days before

Sep 1·entry $279.23·now $323.04

+15.69%

since Sep 1

AIEQ · Weight decrease · 2d

weight 0.390% → 0.050% (-0.340 pp)·stock up 10.6% in the 30 days before

Aug 2·entry $206.25·now $323.04

+56.63%

since Aug 2

AIEQ · Weight increase · 2d

weight 0.350% → 0.390% (+0.040 pp)·stock up 13.6% in the 30 days before

Jul 30·entry $201.56·now $323.04Chased

+60.27%

since Jul 30

AIEQ · Weight decrease · 2d

weight 0.370% → 0.340% (-0.030 pp)·stock up 12.4% in the 30 days before

Jul 23·entry $179.58·now $323.04

+79.89%

since Jul 23

AIEQ · Accumulation · 5d

stock up 5.4% in the 30 days before

Jul 3·entry $192.01·now $323.04Chased

+68.24%

since Jul 3

AIEQ · Weight increase · 2d

stock down 2.4% in the 30 days before

Jul 1·entry $184.22·now $323.04Chased

+75.36%

since Jul 1

AIEQ · New entry · 1d

May 30·entry $188.66·now $323.04Chased

+71.23%

since May 30

AIUPno longer held8 signals

AIUP · Exit · 1d

weight 4.170% → 0 (exited)·stock up 4.3% in the 30 days before

Sep 21·entry $261.31·now $323.04

+23.62%

since Sep 21

AIUP · Weight decrease · 2d

weight 4.480% → 4.170% (-0.310 pp)·stock up 3.7% in the 30 days before

Sep 18·entry $260.21·now $323.04

+24.15%

since Sep 18

AIUP · Accumulation · 5d

weight 4.560% → 4.660% (+0.100 pp)·stock up 5.2% in the 30 days before

Sep 14·entry $265.67·now $323.04Chased

+21.59%

since Sep 14

AIUP · Accumulation · 5d

weight 4.560% → 4.610% (+0.050 pp)·stock up 8.6% in the 30 days before

Sep 11·entry $262.40·now $323.04Chased

+23.11%

since Sep 11

AIUP · Weight increase · 2d

weight 4.320% → 4.600% (+0.280 pp)·stock up 10.3% in the 30 days before

Sep 10·entry $260.98·now $323.04Chased

+23.78%

since Sep 10

AIUP · Weight decrease · 2d

weight 4.610% → 4.320% (-0.290 pp)·stock up 26.3% in the 30 days before

Sep 4·entry $275.09·now $323.04

+17.43%

since Sep 4

AIUP · Weight increase · 2d

weight 0 → 4.610% (new)·stock up 32.5% in the 30 days before

Sep 2·entry $280.72·now $323.04Chased

+15.08%

since Sep 2

AIUP · New entry · 1d

weight 0 → 4.560% (new)·stock up 35.4% in the 30 days before

Sep 1·entry $279.23·now $323.04Chased

+15.69%

since Sep 1

Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.

Buffett-style framework

Fails the frameworkas of Sep 27

AIEQ recently showed a trend of increasing its position in Veeva Systems, suggesting a positive outlook or a growth-oriented strategy by that AI ETF. In contrast, AIUP completely exited its position, indicating a neutral or bearish stance. The value-investing framework, however, identifies a 'Fail' for Veeva due to unassessable management, insufficient financial data to confirm health, and a lack of margin of safety, aligning more with AIUP's cautious move while diverging from AIEQ's accumulation.

Circle of CompetenceThe recurring revenue model and specialized, essential software for the stable life sciences industry provide sufficient predictability for long-term cash flow projections.
Economic MoatVeeva benefits from high switching costs due to its deep integration into critical and regulated life sciences workflows, alongside a strong brand and specialized industry expertise.
ManagementLacking specific information on management's candor, capital allocation discipline, and personal equity holdings, a comprehensive evaluation of management, a critical component of the framework, cannot be performed, thereby materially undermining the investment thesis.
Financial HealthCrucial financial metrics such as historical ROE, stable operating margins, debt levels, and owner earnings are not available to confirm consistent financial health under the framework's strict criteria, with the reported ROE of 14.0% also falling short of the 15% average target.
Margin of SafetyThe high valuation multiples (PER 44.78, EV/EBITDA 26.63) suggest that the current price already incorporates significant future growth, making a defensible margin of safety improbable for a value investor.

Veeva Systems operates within a predictable niche with strong competitive advantages, passing the initial stages of the framework. However, the inability to fully assess management quality and financial health due to insufficient data, combined with a high valuation that offers no discernible margin of safety, leads to a 'Fail' verdict for this value-investing analysis. These critical missing pieces and valuation concerns preclude an investment under this disciplined approach.

Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.